baber/WOPTO huggingface dataset:
Patent DE-69220674-D1 (DE)
Inventor: FLOYD JOHN
IPC: C21B11/00
Filed: 1992-09-17
Granted: 1997-08-07
Abstract: PCT No. PCT/AU92/00489 Sec. 371 Date Apr. 19, 1994 Sec. 102(e) Date Apr. 19, 1992 PCT Filed Sep. 17, 1992 PCT Pub. No. WO93/06251 PCT Pub. Date Apr. 1, 1993.A process for smelting iron-containing source material in a reactor containing a slag bath, includes generating heating and reducing conditions in at least one reducing region of the bath by injection of fuel/reductant and oxygen-containing gas by at least one top submerged lance. The source material is fed to the reactor together with additional reductant and with flux at or adjacent the at least one reducing region so as to be subjected to smelting reduction, using coal as the additional reductant. The rates of injection of oxygen and fuel/reductant are controlled to achieve required and sufficient reducing conditions by providing the injected gas with an oxygen content from about 40% to about 100% sufficient for a degree of combustion of the fuel/reductant of from about 40% to about 50%. The CO and H2 generated by the smelting operation, as well as carbon dust carried out of the bath by combustion gases, are subjected to post-combustion in the reactor, enabling efficient heating of the bath while preventing re-oxidization of the bath contents.
Patent DE-69222352-D1 (DE)
Inventor: EMONDS-ALT XAVIER
IPC: C07D211/46
Filed: 1992-04-30
Granted: 1997-10-30
Abstract: The invention relates to compounds of formula: <IMAGE>  in which:     - m is equal to 2 or 3; - Ar represents a phenyl which is unsubstituted or substituted one or more times by a halogen atom, preferably a chlorine or fluorine atom, by a C1-C3 alkyl, by a trifluoromethyl, by an alkoxy in which the alkyl is C1-C3, by a hydroxyl or by a methylenedioxy; a thienyl, pyridyl or imidazolyl group which is unsubstituted or substituted by a C1-C3 alkyl; - Ar' represents a phenyl group which is unsubstituted or mono- or disubstituted by a halogen atom, preferably a chlorine or fluorine atom, by a C1-C3 alkyl, by a trifluoromethyl, by an alkoxy in which the alkyl is C1-C3, by hydroxyl or by a methylenedioxy; a thienyl group; an imidazolyl group or a benzothienyl group which is unsubstituted or substituted by a halogen, preferably by a chlorine or fluorine atom; a naphthyl group which is unsubstituted or substituted by a halogen, preferably by a fluorine atom; a biphenyl group; an indolyl which is unsubstituted or substituted on the nitrogen by a benzyl group; - X represents an oxygen atom, a sulphur atom, a sulphone or a sulphoxide, an -NH- group, a group <IMAGE> or a group <IMAGE> in which Alk is a C1-C3 alkyl group or a group <IMAGE> in which Alk represents a C1-C3 alkylene and X1 and X2 independently represent hydrogen, a C1-C3 alkyl or constitute, with the nitrogen atom to which they are bonded, a heterocycle chosen from pyrrolidine, piperidine or morpholine; - Q represents hydrogen, a C1-C4 alkyl group or an aminoalkyl group of formula -(CH2)q-Am', where q is 2 or 3 and Am' is a piperidino, 4-benzylpiperidino or dialkylamino group, it being possible for each alkyl to contain from 1 to 4 carbon atoms; - R represents hydrogen, a methyl group or a group (CH2)n-L, where n is an integer from 2 to 6 and L is hydrogen or an amino group;   - T represents a group chosen from: <IMAGE> W being an oxygen or sulphur atom, and   - Z represents either M or OM when T represents:  the group <IMAGE> or M when T represents the group <IMAGE> M represents hydrogen or a straight or branched C1-C6 alkyl; an  alpha -hydroxybenzyl, an  alpha -alkylbenzyl or a phenylalkyl in which the alkyl group comprises 1 to 3 carbon atoms, unsubstituted or mono- or polysubstituted on the aromatic ring by a halogen, a hydroxyl, an alkoxy containing 1 to 4 carbon atoms, or an alkyl containing 1 to 4 carbon atoms; a pyridylalkyl in which the alkyl group comprises 1 to 3 carbon atoms; a naphthylalkyl in which the alkyl group comprises 1 to 3 carbon atoms; a pyridylthioalkyl in which the alkyl group comprises 1 to 3 carbon atoms; a styryl; a 1-methylimidazol-2-ylthioalkyl in which the alkyl group comprises 1 to 3 carbon atoms; a 1-oxo-3-phenylindan-2-yl; an unsubstituted, mono- or polysubstituted aromatic or heteroaromatic group; or to one of their salts with inorganic or organic acids or to one of their quaternary ammonium salts formed with the nitrogen of piperidine. Application: Antagonists of receptors of neurokines (neurokins).
Patent DE-69222429-D1 (DE)
Inventor: PECHEUR ANTOINE
IPC: A61F15/00
Filed: 1992-11-12
Granted: 1997-10-30
Abstract: The orthopedic apparatus of the invention is comprised of a board (1) which is sufficiently wide and long to receive the pelvis of a patient, and a small plank (3) arranged obliquely at the vicinity of the first extremity (6) of the board (1). The patient may lay on his/her back on the board (1), and the plank (3) maintains one of the lower members when making the dressing or the immobilization of the lower member with plaster or resin.
Patent DE-69229496-D1 (DE)
Inventor: SEKI TAKAHITO
IPC: G11B20/18
Filed: 1992-12-21
Granted: 1999-08-05
Abstract: In a digital video tape recorder that has rotary magnetic heads (13A, 13B) for recording digital video information on a magnetic tape in the form of data blocks having a predetermined length, an ID signal is generated for each data block. The ID signal includes a number of data bits which identify the address of the data block, the information contained in the data block, and so forth. For the purpose of generating error code parity symbols, the ID signal is divided into a sequence of four-bit symbols, and at least two parity symbols are generated (10A, 10S, 10V) according to an error correction code for correcting errors in the sequence of four-bit symbols. The ID signal and parity symbols are recorded together on the magnetic tape. In this way, error correction can be performed on the ID signal during reproduction. <IMAGE>
Patent DE-69230986-D1 (DE)
Inventor: SHIMMICK JOHN
IPC: A61F9/01
Filed: 1992-08-03
Granted: 2000-06-08
Abstract: A method for performing concurrent spherical and cylindrical corrections to the corneal surface of the eye to reduce myopia and astigmatism. A laser beam irradiates the corneal surface via a variable diameter iris and a slot produced by a pair of translatable blades. The width of the slot and the diameter of the iris are varied as the laser is pulsed to produce a toric ablation of the corneal surface. Alternatively, the laser beam is passed through a succession of apertures in a tilted variable aperture element to produce toric ablation. The total number of laser pulses required to effect both types of correction is equal to the number required for the spherical correction alone, reducing the laser power and the procedure time. The toric ablation produces no steep end walls as with standard cylindrical ablation procedures, thereby eliminating hyperopic shift and minimizing flattening along the ablated cylinder axis. <IMAGE>
Patent DE-69232963-D1 (DE)
Inventor: MUELLER MARTIN W- HEIDELBERG
IPC: A61K47/48
Filed: 1992-06-19
Granted: 2003-04-24
Abstract: The present invention relates to the use of human paillomavirus 16 (HPV-16) E7-gene derived peptides fot the diagnostic identification of HPV-16-associated invasive cervical cancer.
Patent DE-69233480-D1 (DE)
Inventor: MADDON PAUL J
IPC: A61K47/48
Filed: 1992-02-10
Granted: 2005-03-17
Abstract: This invention provides an expression vector encoding a CD4-gamma2 chimeric heavy chain homodimer. This invention also provides an expression vector encoding the heavy chains of a CD4-IgG2 chimeric heterotetramer. Finally, this invention provides an expression vector encoding the light chains of a CD4-IgG2 chimeric heterotetramer.
Patent DE-69300451-D1 (DE)
Inventor: WONG PATRICK
IPC: A61K9/00
Filed: 1993-01-08
Granted: 1995-10-12
Abstract: The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial delay period to startup or activation being of a predetermined length of time. The delivery of the agent formulation from the dispensing device, once begun, is continued over a predetermined prolonged period of time.
Patent DE-69303339-D1 (DE)
Inventor: BRINKERHOFF RONALD J
IPC: A61B17/115
Filed: 1993-09-17
Granted: 1996-08-01
Abstract: An endoscopic surgical instrument is disclosed which is particularly facilitated for grasping the anvil portion (14) of a circular surgical stapling device (10). The present instrument includes a generally elongated shaft (42), with a pair of cooperating jaw members (46,48) disposed at the distal end (50) of the shaft (42). The jaw members (46,48) cooperate in a pincer-like action for gripping the anvil portion (14) of the associated surgical stapler therebetween. The jaw members (46,48) include cooperating jaw portions (70,72,74), each of which defines a semi-cylindrical gripping surface. The jaw portions (70) are angularly disposed relative to the longitudinal axis of the associated shaft (42), and are otherwise configured to facilitate gripping and manipulation of the anvil portion (14) of the surgical stapling device, as well as tissue manipulation. <IMAGE>
Patent DE-69305019-D1 (DE)
Inventor: DUPUIS CHRISTINE
IPC: A61Q5/06
Filed: 1993-07-22
Granted: 1996-10-31
Abstract: The lacquer contains, in a suitable aerosol container, a cosmetically acceptable aqueous vehicle, N-(carboxybutyl)chitosan as a film-forming substance and dimethyl ether as a propellent agent. After application, this lacquer leads to excellent fixing of the hair.
Patent DE-69317044-D1 (DE)
Inventor: CAUWENBERGH GERARD FRANS MARIA
IPC: A61K8/00
Filed: 1993-03-12
Granted: 1998-03-26
Abstract: The use of a compound having formula ((cis)-(I)), wherein R represents methyl or ethyl, for regulating the greasiness of the skin, particular novel physical forms of said compound, cosmetic compositions comprising said agent, processes for preparing said agent and compositions, and a method of reducing the greasiness of the skin.
Patent DE-69403085-D1 (DE)
Inventor: JONES ALLAN
IPC: C08L77/12
Filed: 1994-08-08
Granted: 1997-06-12
Abstract: This invention relates to naphthalenedicarboxylic acid containing polymer compositions having reduced fluorescence. More specifically, the process involves melt blending a naphthalenedicarboxylic acid containing polymer with 0.1 to 5 weight percent of a fluorescence quenching compound selected from a halogen containing aromatic compound, an aromatic ketone or a naphthol compound and thermoforming the blend into an article. The blends are useful for packaging applications where clarity and/or aesthetic appeal are of concern.
Patent DE-69406814-D1 (DE)
Inventor: TUNC DEGER
IPC: C08G63/90
Filed: 1994-02-08
Granted: 1998-01-02
Abstract: A process of purifying and stabilizing a high molecular weight polylactide polymer by contacting solid polymer particles with methyl alcohol and subsequently acetone.
Patent DE-69423146-D1 (DE)
Inventor: HOCK JANET MARY
IPC: A61K38/29
Filed: 1994-07-18
Granted: 2000-04-06
Abstract: The present invention includes a method for increasing bone mass in a subject by administration of PTH and raloxifene. Another aspect of the invention is a method for treating bone loss in a subject by administration of PTH and raloxifene. The invention further provides for a composition of PTH and raloxifene for increasing bone mass in a subject. Another aspect of the invention is a composition of PTH and raloxifene for treatment of bone loss in a subject.
Patent DE-69424165-D1 (DE)
Inventor: BERGMAN CARL
IPC: B01J3/03
Filed: 1994-06-08
Granted: 2000-05-31
Abstract: PCT No. PCT/SE94/00551 Sec. 371 Date Nov. 27, 1995 Sec. 102(e) Date Nov. 27, 1995 PCT Filed Jun. 8, 1994 PCT Pub. No. WO94/28745 PCT Pub. Date Dec. 22, 1994A device for high-pressure treatment, in particular of liquid substances which contain components with a consistency different from that of the liquid. The device comprises a cylinder member (1), two end members (2, 3), a high-pressure piston (4), two high-pressure seals (8, 9) and connection means comprising channels and valve members to conduct the substance to and from the cylinder member (1). When the substance is pressurized, the cylinder member (1), at least one of the end members (3), the high-pressure piston (4) and the two high-pressure seals (8, 9) delimit a high-pressure chamber (10). The connection means are arranged outside the high-pressure chamber and preferably in respective end members (2, 3).
Patent DE-69425512-D1 (DE)
Inventor: YOUNG W
IPC: A61L31/00
Filed: 1994-04-12
Granted: 2000-09-14
Abstract: Catheters and other medical devices include a non-metallic member having paramagnetic ionic particles fixedly incorporated therethrough in order to provide enhanced detectability when viewed by magnetic imaging regardless of the orientation of the non-metallic member in the magnetic field. Catheters are usually formed from polymeric tubing, and the paramagnetic ionic particles are usually formed from paramagnetic ions incorporated with water or other proton-donating fluid into carrier particles, such as zeolites, molecular sieves, clays, synthetic ion exchange resins, and microcapsules. Catheters and other medical devices include a non-metallic member having small iron and/or superparamagnetic particles fixedly incorporated therethrough or thereover in order to provide enhanced detectability when viewed by magnetic imaging. Catheters are usually formed from polymeric tubing, and the iron and/or superparamagnetic particles at or near the surface of the catheter interact with the water protons of the surrounding patient's body to provide image enhancement regardless of the orientation of the polymeric or other non-metallic material in the magnetic field.
Patent DE-69429266-D1 (DE)
Inventor: JACKSON KEVIN
IPC: B42D25/29
Filed: 1994-06-06
Granted: 2002-01-10
Abstract: PCT No. PCT/AU94/00302 Sec. 371 Date Dec. 7, 1995 Sec. 102(e) Date Dec. 7, 1995 PCT Filed Jun. 6, 1994 PCT Pub. No. WO94/29119 PCT Pub. Date Dec. 22, 1994A security document or token such as a banknote (40) is provided which has a transparent portion (42) of plastics material which includes a security device (50). The region (44) surrounding the transparent portion (42) and preferably all the remaining part of the banknote (40) is printed with indicia. The security device (50) includes regions (52, 54, 56 and 58) of embossed lines extending at different angles to each other defining different shapes that are visible to a greater or lesser extent upon transmission and reflection of light as the note is tilted, rotated or viewed from different angles relative to a light source. The embossed lines in some of the regions (52 and 54) are finer than coarser and deeper and more widely spaced lines in the other regions (56 and 58). The coarser, deeper lines are of such a thickness and width to be detected by touch in addition to being visible by the naked eye. There is also provided a method of and apparatus for producing a banknote with a security device in accordance with the invention in which the transparent portion of the note is embossed during an intaglio printing process.
Patent DE-69431906-D1 (DE)
Inventor: THOMAS L
IPC: H04N7/00
Filed: 1994-10-17
Granted: 2003-01-30
Abstract: An audience measurement system (10) collects data representative of tuned programs rather than of tuned channels, and includes (i) a household metering apparatus (14) which records ancillary codes or extracts program signatures from the programs if no ancillary codes are found therein, (ii) a reference apparatus (32) which monitors broadcast programs to be monitored, which extracts reference signatures therefrom, which records whatever ancillary codes may be associated with these broadcast programs and, if no ancillary codes are present, which compresses and stores a digital replica representative of the broadcast programs to be monitored, (iii) a data collection apparatus (36) which compares the household and reference data to determine (a) which of the broadcast programs to be monitored were selected for viewing and/or listening, (b) which of the metered households selected the broadcast programs to be monitored for viewing and/or listening, and (c) at which times the broadcast programs to be monitored were selected for viewing and/or listening. <IMAGE>
Patent DE-69501349-D1 (DE)
Inventor: ABUSLEME JULIO A
IPC: C08F2/44
Filed: 1995-03-10
Granted: 1998-02-12
Abstract: Cyclopentanes alkyl-substitued with one or more C1-C6 alkyls are used as chain transfer agents in (co)polymerization reactions carried out, either in suspension or in aqueous emulsion, at low temperatures, comprised between -30 DEG  and +30 DEG C, for preparing thermoplastic hydrogen-containing fluoropolymers, such as for instance ethylene/chlorotrifluoroethylene and ethylene/tetrafluoroethylene copolymers, or homopolymers and copolymers of vinylidenefluoride. They are transfer agents having high efficiency, which are liquid and thus can be easily handled and dosed, non-toxic, yielding alkyl end groups of high thermal stability.
Patent DE-69505618-D1 (DE)
Inventor: LAIB DOUGLAS M
IPC: A47J19/06
Filed: 1995-08-11
Granted: 1998-12-03
Abstract: First and second elongate arms each include a hand grip portion and a press component, comprising a compartment on the first arm remote from said hand grip portion. The compartment includes an inner wall with multiple draining apertures through for discharge of effluent from a pressed foodstuff. The press component on the second arm comprises a pressure member on the second arm remote from the hand grip portion for compression of a foodstuff compartment. The pressure member is configured for close slidable reception in the compartment with pivot pivotally joining the arms remote from the hand grip portions and the press components. Selective pivotal movement of the hand grip portions is towards and away from each other will produce a corresponding movement of the press components toward and away from each other. The pivot comprises hinges on the first and second arms aligning with each other and defining a passage through transversely of the arms. A hinge pintle is removably received in the passage and retains the arms of pivotal movement of the arms relative to each other.
Patent DE-69507365-D1 (DE)
Inventor: EBBING PETER F
IPC: B01D1/30
Filed: 1995-04-18
Granted: 1999-03-04
Abstract: A method and apparatus for dry vapor generation. A manifold assembly with a channel conveys liquid from a liquid source to a vessel (12) secured to the manifold assembly. The vessel includes a fill tube (152) connected to the manifold assembly's channel, and a settling chamber (14). A heater (150) heats liquid in the vessel to generate a vapor that enters the settling chamber (14) through its vapor inlet. The manifold assembly comprises two blocks in mating engagement wherein the outlet port of the first block is aligned with the inlet port of the second block. The outlet port of the second port block is connected to the vessels fill tube. <IMAGE>
Patent DE-69507605-D1 (DE)
Inventor: LEFLECHER RENE
IPC: A23L9/10
Filed: 1995-04-13
Granted: 1999-03-11
Abstract: Base comprising sugar, a thickening agent, sodium alginate, a sequestering agent and a flavouring agent, at least the sodium alginate being ground.
Patent DE-69511311-D1 (DE)
Inventor: HIROSE MIFUNE
IPC: B41J2/21
Filed: 1995-02-21
Granted: 1999-09-16
Abstract: A recording paper comprising pulp fibers and a filler has a surface where pulp fibers bared to the surface and pulp fibers covered with particles are present together in portions. The quantity of ink transfer at a minimum ink-shoot time interval for adjacent dots with different colors as measured by the Bristow's test method is not smaller than a maximum shot-in ink quantity per unit area of recording system used.
Patent DE-69512152-D1 (DE)
Inventor: MARTIN GERARD
IPC: F23G5/027
Filed: 1995-06-23
Granted: 1999-10-21
Abstract: Procedure for thermal treatment of waste consists of pyrolysis of the waste, recycling of the pyrolysis gas as a combustible for the pyrolysis and post-treatment of the solids output of pyrolysis in that the combustible solids output at the post treatment of the pyrolysis solids can be burnt in a cyclone furnace (5) or stocked. The hot gas output of the cyclone furnace can be used to recoup energy (11), and the post-treatment consist essentially of purification of carbon solids. The pyrolysis gas can be burnt in the cyclone furnace (5) or in the means of recouping energy (11). The post-treatment consists of cooling the solids, extracting and rinsing the mineral materials, hot washing to dissolve notably chlorine salts, and separating the water and carbon solids. <IMAGE>
Patent DE-69515369-D1 (DE)
Inventor: COLLIN NATHALIE
IPC: C09K23/54
Filed: 1995-05-10
Granted: 2000-04-13
Abstract: New w/o emulsions contain polyalkylsilsesquioxane microspheres (see below), contain no surfactant, and have a droplet size of 0.1-20 mu m. Also claimed is a cosmetic treatment process comprising applying an emulsion as above to the skin.
Patent DE-69522701-D1 (DE)
Inventor: MEZEI MICHAEL
IPC: A61K9/127
Filed: 1995-10-20
Granted: 2001-10-18
Abstract: PCT No. PCT/HU95/00052 Sec. 371 Date Aug. 5, 1997 Sec. 102(e) Date Aug. 5, 1997 PCT Filed Oct. 20, 1995 PCT Pub. No. WO96/12472 PCT Pub. Date May 2, 1996This invention provides liposomic composition, containing as active ingredient (-)-N- alpha -dimethyl-N-(2-propynylphenylethylamine) (selegilin) and/or salt thereof. This composition contains: 0.1-40% by weight of selegilin and/or a salt thereof, 2 to 40% by weight of lipids, preferably phospholipids, 0 to 10% by weight of cholesterol, 0 to 20% by weight of an alcohol, 0 to 25% by weight of a glycol, 0 to 3% by weight of an antioxidant, 0 to 3% by weight of a preserving agent, 0 to 2% by weight of a viscosity influencing agent, 0 to 50% by weight of cyclodextrin or a cyclodextrin derivative and 30 to 90% by weight of water. This invention relates to pharmaceutical composition, containing the liposomic composition described and if desired, usual filling and diluting agents and other auxiliaries, preferably in oral, parenteral or transdermal form. This invention provides the process for the preparation of liposomic compositions containing selegilin and/or salt thereof. Accordingly liposomic composition of this invention may be administered for the treatment of Alzheimeir's disease, Parkinson's disease, depression, stroke, motion sickness or myelitis.
Patent DE-69524674-D1 (DE)
Inventor: RYAN O
IPC: G10L19/00
Filed: 1995-01-12
Granted: 2002-01-31
Abstract: A method and receiver for accessing data carried by a broadcast signal permits the user to listen to specific information when required. A radio or television receiver is arranged to extract audio data from a broadcast signal and to store that extracted audio data as a database in memory. The receiver has a user interface which enables the user to select, by way of a set of menus, particular items of the stored information. Typically, the system includes sufficient storage to store information for about ten hours of audio. The audio data is compressed for transmission and the receiver has decompression circuitry for decompressing the accessed stored data. A speech synthesiser is provided to transform the selected data into speech. <IMAGE>
Patent DE-69525336-D1 (DE)
Inventor: HICKEY NEIL
IPC: G06F9/44
Filed: 1995-04-18
Granted: 2002-03-21
Abstract: An apparatus and method for converting a first user interface used for existing applications running on a host computer to a second user interface for use on a client computer. The apparatus intercepts prompts and request for input from the host, converts them to a form appropriate for use on the client computer, and passes the converted prompts and requests to the client. The apparatus can store information for use at a later prompt or request, branch on the stored value to vary path execution, and handle errors generated by incorrect input.